3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Burkitt Lymphoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Dendritic Cell Sarcoma, Interdigitating
1
Cardiotoxicity
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Refractory
1
Interventions
Cyclophosphamide
50
Vincristine
49
Doxorubicin
44
Prednisone
42
Rituximab
32
Radiotherapy
27
Etoposide
27
Methotrexate
24
Filgrastim
24
Cytarabine
23
Dexamethasone
15
Granulocyte Colony-Stimulating Factor
13
Bleomycin
13
Vinblastine
12
Peripheral Blood Stem Cell Transplantation
12
Leucovorin
11
Gene Expression Profiling
10
Bortezomib
10
Immunohistochemistry
9
Procarbazine
8
Polymerase Chain Reaction
8
Gemcitabine
8
Melphalan
7
Amplified Fragment Length Polymorphism Analysis
7
VAP-cyclo protocol
6
Mercaptopurine
6
Ifosfamide
6
Dacarbazine
6
Carmustine
6
Microarray Analysis
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Lymphoma
×
hydrocortisone hemisuccinate
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled